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brief communications
Synergistic effects of
traumatic head injury
and apolipoprotein-~4
in patients with
Alzheimer’s disease

Article abstract-The apolipoprotein-~4allele increases t h e risk of
Alzheimer’s disease (AD), but cerebral deposition of P-amyloid with age, a
genetic mutation, or head injury may contribute to the pathogenesis of this
disease. We examined the risks of AD associated with traumatic head injury
and apolipoprotein-~4in 236 community-dwelling elderly persons. A 10-fold
increase in the risk of AD was associated with both apolipoprotein-~4and a
history of traumatic head injury, compared with a two-fold increase in risk
with apolipoprotein-~4alone. Head injury in the absence of an apolipoprot e i n - ~ 4allele did not increase risk. These data imply t h a t the biological
effects of head injury may increase the risk of AD, but only through a synergistic relationship with apolipoprotein-~4.
NEUROLOGY 1995;45:555-557

R. Mayeux, MD; R. Ottman, PhD; G. Maestre, MD; C. Ngai, BS; M.-X. Tang, PhD; H. Ginsberg, MD;
M. Chun, MD; B. Tycko, MD, PhD; and M. Shelanski, MD, PhD
Data collection. A semi-structured interview, previRoberts et all observed cerebral P-amyloid (PAP)
ously established as reliable, was used to inquire about
deposits and neurofibrillary tangles in the brains of
head injury with loss of consciousness.2 For ethnic group
professional and amateur boxers who were dementclassification, we used the format suggested by the 1990
ed before death and in individuals who died as a
United States Census Bureau.
result of severe head injury. Further, some but not
Data analysis. Allele frequencies for patients with AD
all epidemiologic studies have found a n association
and controls were estimated by counting alleles and calbetween Alzheimer’s disease (AD) and head injury.2
culating sample proportions. Frequencies of Apo-E genoRoberts et all also found increased expression of ptypes in patients and controls were compared using the
amyloid precursor protein (PAPP)following trauma
chi-square test. The frequencies for t h e demographic
to the brain; this has been interpreted as a n acute
variables (including ethnic group) and risk factors were
compared between cases and controls using chi-square
response to neuronal injury. They considered these
analyses. Both univariate and multivariate odds ratios
observations to be compatible with a major role for
for AD associated with Ap0-d were calculated from logisamyloid deposition i n t h e pathogenesis of AD
tic regression adjusting for age and ethnic group.
because cerebral PAP deposition is considered a
key step in a “neurotoxic” cascade leading to neuResults. Patients with AD and controls were simiritic plaques and neuronal death.3
lar in age (AD 74.0 f 10.5 [SDI, controls 72.0 f 9.1
Because individuals homozygous or heterozy[SD]), g en d er ( % women: AD 74.5%, controls
gous for apolipoprotein-€4 (Ap0-d) are a t signifi69.1%), and ethnic group (African American: AD
cantly higher risk for AD t h a n individuals with
50.7%, controls 49.3%; Hispanic: AD 48.9%, conother genotype^,^ and because the amount of ceretrols 51.1%; and white: AD 44%, controls 56%). AD
bral PAP deposition in AD may be related to the
patients had significantly fewer years of education
specific Apo-E g e n ~ t y p ewe
, ~ hypothesized that a
than did controls (AD 8.5 5.6, controls 10.4 4.8;
history of traumatic head injury and the presence
p < 0.01).
of an Ap0-d allele would have a synergistic effect
The allele frequency of Apo-d was significantly
on t h e risk of AD among community-dwelling
greater among patients with AD t h an in controls
elderly people.
(0.29 versus 0.16; x2 = 13.4, p c 0.001). The Apo-€4
allele frequency did not differ by age, gender, or
Methods. Blood for genomic DNA testing was obtained
years
of education within either cases or controls.
from 113 patients meeting research criteria for AD and
A
p
o
d
allele frequency was similar for patients
from 123 healthy elderly persons. Both groups of subjects
w i t h AD r e g a r d l e s s of e t h n i c g r o u p (African
resided in the same region of northern Manhattan and
American 0.33, Hispanic 0.34, and white 0.30), but
were identified in a population-based study of AD and
related dementias. Eight of the 113 cases of AD were
differed significantly among controls (African
autopsy confirmed. Cases and controls were matched for
American 0.28, Hispanic 0.13, and white 0.10; x2 =
age (within 5 years), gender, and ethnic group (African
11.2, p < 0.05). The odds ratio (OR) for AD associatAmerican, Hispanic, or white).
ed with homozygosity for Apo-€4 was 3.9 (95% CI,
Gnomic DNA was amplified by polymerase chain reac1.2 to 13.2, p c 0.01) and that associated with hettion, using reaction conditions modified from those
erozygosity
was 2.0 (95% CI, 1.2 to 3.6, p c 0.01)
described by Hixson and Vernier.6 The genotypes were
compared
with
other Apo-E genotypes. Adjustments
determined by the sizes of DNA fragments present, viewed
for age, education, and ethnic group did not result
and photographed under ultraviolet light after staining
in a change in the magnitude of the OR for AD assowith 0.5 pg/ml of ethidium bromide. All genotypes were
ciated with Ap0-d homozygosity or heterozygosity.
determined without knowledge of patient-control status.

*

*
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Table. Independent effects of apolipoprotein-e4(Ap0-E.Q)and head injury among patients and controls

I
Head
injury
No
No
Yes
Yes

Ap0-d
(one or more alleles)

Alzheimer's
disease

No
Yes
No
Yes

52
48
6
7

Controls

Odds ratio (95%CI)*

78

1.0,reference
2.0 (1.2-3.6)T
1.0(0.3-2.9)
10.5 (1.3-88.7)t

35
9
1

Adjusted for age and
education (95%CI)*
1.0,reference
2.0 (l.l-3.5)t
1.0(0.3-3.2)
10.2(1.2-89.0)t

* 95% confidence interval for the odds ratio. In this stratified analysis, we had 80% power to detect an odds ratio of 9.6 or more for the interaction.
? Statistical significance,^ < 0.05.

Thirteen patients (11.5%)with AD had a history
of head trauma associated with loss of consciousness that preceded onset of dementia by at least 2
years, whereas 10 (8.1%)controls reported a similar injury. The distribution of head injury was similar across ethnic groups. The OR for AD associated
with head injury was 1.5 (95% CI, 0.5 to 3.5, p =
0.5). To examine the relationship between the presence of Ap0-d and head injury in terms of their
joint and independent effects on the risk of AD, we
stratified the cases and controls by these two variables (table). There was no difference in age, gender, or ethnic group among the cases and controls
across the four strata. Using as the reference group
persons with neither a history of head injury nor
an Apo-€4 allele, we estimated the OR for AD associated with both a history of traumatic head injury
and the presence of at least one Apo-€4 allele (OR =
10.5; 95% CI, 1.3 to 87.81,traumatic head injury
alone (OR = 1.0; 95% CI, 0.3 to 2.91, and the presence of Apo-€4 alone (OR = 2.0; 95% CI, 1.1to 3.51,
adjusting for age by logistic regression. Thus, the
OR for the joint effect of head injury and Apo-€4
exceeded t h a t expected from t h e independent
effects of both risk factors (ie, 1.0 x 2.0 = 2.01, suggesting a synergistic relationship. We also formally
tested for interaction using logistic regression. In
this model, the OR for Apo-€4was 2.1 (95% CI, 1.2
to 3.6, p c 0.011, that for head injury was 1.0 (95%
CI, 0.3 to 3.1, p = l.O), and that for the interaction
(ie, Apo-~4*headinjury) was 5.1 (95% CI, 0.6 t o
43.8, p = 0.1).
Discussion. This investigation provides evidence
to suggest a synergistic relationship between an
environmental risk factor (head injury) and a
marker of genetic susceptibility to AD (Ap0-d).
Although the number of patients and controls with
head injury we report is modest, the frequency of
this risk factor approximates the lifetime frequency
we observed i n a previous s t u d y in t h i s
community.2 In the absence of Apo-€4, the OR for
head injury was not elevated; thus, our results
indicate that the effect of head injury on AD risk
may be restricted to persons either homozygous or
heterozygous for Apo-€4. The findings are most consistent with a model in which an environmental
risk factor has no effect alone, yet it exacerbates
566 NEUROLOGY 45 March 1995

the effect of genetic s u s ~ e p t i b i l i t yThe
. ~ OR for
interaction using logistic regression was elevated;
however, it was not statistically significant, but
this analysis was very conservative. To detect a significant interaction of the same magnitude using
this approach we would need nearly twice as many
subjects.8 As such, our conclusions must remain
tentative, but they are consistent with two major
views on the pathogenesis of AD.
The pathology of dementia in boxers was considered to consist mostly of neurofibrillary tangle formation, but Roberts et al,l using immunostaining,
identified PAP deposits in brain as well. Moreover,
they also detected diffuse deposits of PAP, not neurofibrillary tangles, in the upper layers of the neocortex of patients with fatal head injuries but no
history of dementia, as well a s increased PAPP
immunoreactivity in all head-injury cases examined.' The latter observation might suggest that
PAPP is increased as an acute-phase response t o
neuronal injury, which, in turn, leads to PAP deposition in cortex. The amyloid hypothesis converges
on the role of cerebral PAP deposition as the initial
event leading to the formation of neuritic plaques
and subsequent neuronal death. PAP deposition
may result in cell death by binding t o specific
molecules on the cell surface or by rendering neurons more susceptible to excitotoxic, ischemic, or
other metabolic constituent^.^ Because Apo-E is
involved in cholesterol transport, it may sequester
proteins such a s amyloid in response t o brain
i n j ~ r yPoirier
.~
et a19 found Apo-E mRNA and the
number of Apo-E immunoreactive cells increased
following electrolytic lesions of rat hippocampus,
and proposed that Apo-E could be a trophic factor
secreted by astrocytes for membrane synthesis and
synaptogenesis in response to injury. Thus, individuals with one or more copies of the Apo-€4 allele
might be more likely to deposit PAP in cortex following head injury than individuals with other
genotypes.
Our results would also be compatible with a
recent hypothesis forwarded by Strittmatter et al, lo
who proposed that the absence of Apo-€3 results in
more rapid tau phosphorylation, leading to instability of the microtubule system in neurons and the
formation of paired helical filaments and neurofibrillary tangles, thereby increasing the risk of AD.

Thus. the formation of neurofibrillarv tangles in
people with a history of head injury k h o become
demented might be related to their Apo-E genotype
as well to any direct effect of the trauma.
The exact mechanism underlying the role of ApoE in the pathogenesis of AD remains unresolved,
but the Apo-E genotype may specify a degree of
genetic susceptibility to AD that can be exacerbated by the effects of other genes or environmental
risk factors such as traumatic head injury.
Y
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Article abstract-We report the first case of pathologic findings from
brain biopsy in a patient with Sneddon’s syndrome. The observations suggest that Sneddon’s syndrome is not a vasculitis but is more comparable to
the autoimmune vasculopathies such as the antiphospholipid antibody syndrome. Vascular thrombosis and emboli from cardiac sources are the likely
causes of stroke in most cases. The success of warfarin in the treatment of
antiphospholipid syndromes and the failure of immunosuppression and
aspirin in the treatment of Sneddon’s syndrome argue that warfarin anticoagulation may be the most appropriate intervention currently available.
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Paul S. Mischel, MD; and Jeffrey L. Cummings, MD

Sneddon’s syndrome is the association of cerebral
vascular disease and livedo reticularis (racemosa).
Its prevalence and its etiology are ~ n k n o w n The
.~
average time to diagnosis of Sneddon’s syndrome is
10 years from the onset of symptoms, and it is likely
an underdiagnosed ~ondition.~
Although some studies have reported that up to 35% of patients with
this syndrome test positive for antiphospholipid
antib~dies,~
most test n e g a t i ~ e . ~ .Reports
~ . ~ , . “ of dermatologic pathology have been conflicting; while
some have revealed vasculitic features including
small-vessel endothelitis and inflammatory obstruction,”.“others describe a noninflammatory vascu-

lopathy restricted to small and medium-sized arteri e ~ .The
~ ? brain
~
pathology has been inferred from
MRI and CT studies; no brain biopsies and only one
limited autopsy specimen have been r e p ~ r t e d .In
~.~
addition, only a few reports2-6s8
have included angiographic or single-photon emission computerized
tomographic (SPECT) studies.
We report the unusual case of a young woman
with a progressive vascular dementia due to
Sneddon’s syndrome and discuss the results of her
clinical and laboratory evaluation, including cerebral angiography, in the context of the histopathologic findings in her brain biopsy.
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